Epstein File EFTA02404248: Targeted (DS11)

Epstein Index›Documents›EFTA02404248

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA02404248: Targeted (DS11)

Media / PressDate unavailableEFTA024042481 keyword hits

0

views

0

shares

0

reactions

0

persons

1

keywords

3

excerpts

This document contains business press materials discussing Foundation Medicine and genomic research related to targeted therapies for liver cancer. The excerpt references company growth strategies including domestic operations acceleration, international expansion, R&D investment, and infrastructure development. No individuals are named and no dates are specified in the available excerpt.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

targeted

📋 Key Excerpts3

PersonKeyword

Excerpt 1

. * Proceeds t= be used to accelerate the growth of domestic operations, **targeted** growt= of international operations, R&D, infrastructure build-out, f=

Excerpt 2

source-email_rt_mc_press_1> (Busines Wire) * Foundation Medicine and Collaborators Identify High Incidence of Genomic Alterations =inked to **Targeted** Therapies

Excerpt 3

793922&extra=&&&3000&&&http://=eekingalpha.com/pr/9048033-foundation-medicine-and-collaborators-identif =igh-incidence-of-genomic-alterations-linked-to-**targeted**-therapies-in-liverecancer-data-published-in-the